813PTreatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment. (23rd October 2018) - Robbrecht, D G; van Soest, R J; Tannock, I F; Oudard, S; Tombal, B; Eisenberger, M; Mercier, F; de Wit, R